Delivery Order SPE2DB22D1106-SPE2DB25FEDJ3

Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,723.76 firm fixed-price delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of March 15, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,819.58 firm fixed-price delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a prescription medication. The contract has an ultimate completion date of September 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,964.50 firm fixed-price delivery order is for the supply of 4566243184 OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, with a period of performance ending on October 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,734.40 firm fixed-price delivery order contract covers the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty medication, to support military healthcare programs. The award is a child contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
The federal contract award with ID SPE2DB22D3501|SPE2DB24FVJ38 is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,585.80 firm-fixed-price contract is for the supply of 4,564,340,496 units of the pharmaceutical product OVIDREL 250 MCG/0.5 ML SYRG 0.5ML. The award has an ultimate completion date of April 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) was issued by the Defense Logistics Agency (DLA), a defense agency, for the delivery of 4,565,332,650 units of the pharmaceutical product OVIDREL 250 MCG/0.5 ML SYRG 0.5ML. The contract has a ceiling value of $2,474.85 and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of August 5, 2024, and was awarded on August 2, 2024. Amerisourcebergen, a major pharmaceutical distributor,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,697.52 firm fixed-price delivery order is for the supply of 250 mcg/0.5 mL syringes of the pharmaceutical product Ovidrel. The award does not have a set-aside designation. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This federal contract award, with the ID SPE2DB22D1106|SPE2DB24FFKK9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product, with a ceiling value of $4,066.82 and a completion date of September 3, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp, a...
The Defense Logistics Agency Troop Support Medical awarded a $113,490 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562052088 Ovidrel 250 mcg/0.5 ml syrg 0.5ml. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 5-6, 2023. As a prime contractor supporting DLA Troop Support Medical, Amerisourcebergen will deliver fertility drug Ovidrel to aid the Defense Health Agency in fulfilling prescription needs for military...
Defense Logistics Agency awarded a $218 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for OVIDREL 250 MCG/0.5 ML SYRG 0.5ML. Place of performance will be in Conshohocken, Pennsylvania. No set-aside designation was used for this order, which must be completed by September 2023. The Defense Logistics Agency supports America's armed forces by providing supplies in healthcare, aviation, and other areas; this order for Ovidrel injection...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEDJ3
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML medical supplies. The contract, valued at $2,100.90, was awarded by the Defense Logistics Agency (DLA) with a completion date of March 18, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 6/16/25, 10:46 AM